Overview

Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which regimen of chemotherapy is more effective for non-small cell lung cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of two regimens of chemotherapy in treating patients who have stage IIIB or stage IV non-small cell lung cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Istituto Nazionale per lo Studio e la Cura dei Tumori
Collaborator:
NCIC Clinical Trials Group
Treatments:
Cisplatin
Gemcitabine
Vinorelbine